Patent · US Active

Monoclonal antibody against duck tembusu virus, hybridoma cell line and application thereof

US9500652B2 · kind B2 · utility

0Cited by
0References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 16, 2012
Grant dateNov 22, 2016
Priority date
Expiry dateJun 6, 2032

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/183
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A monoclonal antibody against the Duck Tembusu virus and a hybridoma cell line secreting the monoclonal antibody, a reagent kit and method for detecting a Duck Tembusu virus antibody, and application of the monoclonal antibody in preparing products for diagnosing the Duck Tembusu virus disease. The monoclonal antibody may bind specifically to E protein of Duck Tembusu virus and has an activity of neutralizing Duck Tembusu virus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.